RE: Brian Goch27 May 2021 13:32
@tillidjohan - not without a deed poll :)
@shandypants2 - many specialities have patients under tight follow up, haematology, renal, transplant, rheumatology etc. Many of whom require weekly bloods. Admittedly the long term stable patients get their 3 months supply of oral iron and that's them sorted. My only point was that it won't take too long at all to pick up the sicker patients in clinics who would benefit from Accrufer, and the revenue stream begins.
The US is a totally different market, prescribing culture and set of ethics. The small team of influential reps and prescribers bodes very well from a sales perspective.